More about PI:

​

Parisa directs the Yousefpour Lab at Columbia University. She completed her postdoctoral training at MIT, supported by the Ludwig Cancer Research Fellowship and NIH NRSA Fellowship. During her postdoc, Parisa integrated synthetic biology and immunoengineering approaches to develop small-molecule-responsive gene circuits, enabling precise temporal control of transgene expression in RNA therapeutics for cancer immunotherapy and vaccine development. She earned her Ph.D. in Biomedical Engineering from Duke University, where she developed albumin-binding drug delivery platforms for cancer and diabetes treatment using drug delivery, biopolymers, and protein engineering approaches. She holds an integrated BS-MS degree in Biotechnology/Bioprocess Engineering from the University of Tehran. Her research centers on engineering next-generation biomolecular therapeutics at the intersection of immunoengineering, synthetic biology, protein engineering, and biomaterials science.

​

Parisa was a recipient of the FLI (First Generation/Low Income) Student Support and Advocacy award from MIT and Rising Stars in Engineering in Health Award  from Columbia University ( in partnership with Johns Hopkins and Cornell Universities)

​